1Gould MK;Maclean CC;Kuschner WG.Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions:a meta-analysis[J],2001.
2Hicks RJ;Kalff V;Mac Manus MP.(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging new diagnosis non-small cell lung cancer,2001(42).
3Schmidt S;Nestle U;Walter K.Optimization of radiotherapy planning for non-small cell lung cancer (NSCLC) using 18FDG-PET,2002(42).
5Spaepen K;Stroobants S;Dupont p.Prognostic value of pogitron emisson tomography (PET) with fluorine-18fluorodeoxygluos ([ 18F ]PDG) after first-line chemotherapy in the non-Hodgkin's lymphoma:is [ 18F]PDG-PET a valid alternative to conventional diagnostic methods?,2001(19).
6Dietlein M;Weber K;Gandjour A.Cost-effective of FDG-PET for the management of potentially operable non-small cell lung cancer:priority for a PET-based strategy after nodal-negative CT results,2000.
7Staib L;Schirrmeister H;Reske SN.Is (18)F-fluorodepxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making?,2000.
8Fong Y;Saldinger PF;Akhurst T.Utility of 18F-FDG positron emission tomigraphy scanning on selection of patients for resection of hepatic colorectal metastases,1999.
9Kresnik E;Mikosch P;Gallowitsch HJ.Evaluation of head and neck cancer with 18F-FDG PET:a comparison with conventional methods[J],2001(7).
10Lonneux M;Lawson G;Ide C.Positron emission tomography with fiuorodeoxygiucose for suspected head and neck tumor recurrence in the symptomatic patient,2000.
